Chao Shi

1.1k total citations
57 papers, 764 citations indexed

About

Chao Shi is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Chao Shi has authored 57 papers receiving a total of 764 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 16 papers in Molecular Biology and 13 papers in Infectious Diseases. Recurrent topics in Chao Shi's work include Viral gastroenteritis research and epidemiology (9 papers), Viral Infections and Immunology Research (7 papers) and Cancer Genomics and Diagnostics (5 papers). Chao Shi is often cited by papers focused on Viral gastroenteritis research and epidemiology (9 papers), Viral Infections and Immunology Research (7 papers) and Cancer Genomics and Diagnostics (5 papers). Chao Shi collaborates with scholars based in China, United States and Germany. Chao Shi's co-authors include Yongjun Guo, Jing Ai, Changjun Bao, Jie Ma, Yuan Xiao Zhu, K. Martin Kortüm, A. Keith Stewart, Patrick Jedlowski, Pengfei Ren and Jianguang Fu and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Chao Shi

55 papers receiving 751 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chao Shi China 15 274 225 141 131 89 57 764
Xiaojun Li China 14 224 0.8× 86 0.4× 88 0.6× 124 0.9× 65 0.7× 43 734
Shiro Miura Japan 17 176 0.6× 63 0.3× 181 1.3× 117 0.9× 114 1.3× 85 869
Dongju Feng China 13 301 1.1× 78 0.3× 202 1.4× 74 0.6× 60 0.7× 17 651
Xueyan Xi China 16 418 1.5× 137 0.6× 225 1.6× 164 1.3× 50 0.6× 49 1.2k
Xiaopeng Wu China 17 348 1.3× 73 0.3× 166 1.2× 86 0.7× 66 0.7× 53 917
Yoo Jin Lee South Korea 17 180 0.7× 195 0.9× 61 0.4× 33 0.3× 55 0.6× 45 656
Ying Dai China 13 247 0.9× 59 0.3× 177 1.3× 26 0.2× 110 1.2× 26 574
Guangming Xiang China 12 181 0.7× 81 0.4× 97 0.7× 29 0.2× 91 1.0× 39 547
Tatsuki Mizuochi Japan 17 186 0.7× 122 0.5× 198 1.4× 57 0.4× 73 0.8× 64 976
Hsiao‐Bai Yang Taiwan 16 229 0.8× 100 0.4× 95 0.7× 125 1.0× 148 1.7× 36 911

Countries citing papers authored by Chao Shi

Since Specialization
Citations

This map shows the geographic impact of Chao Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chao Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chao Shi more than expected).

Fields of papers citing papers by Chao Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chao Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chao Shi. The network helps show where Chao Shi may publish in the future.

Co-authorship network of co-authors of Chao Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Chao Shi. A scholar is included among the top collaborators of Chao Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chao Shi. Chao Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Xiaojuan, Mina Zhang, Xinyang Du, et al.. (2024). Clinical efficacy and safety analysis of aumolertinib in real-world treatment of EGFR-mutated advanced non-small-cell lung cancer. Frontiers in Pharmacology. 15. 1331138–1331138. 5 indexed citations
2.
Li, Zhen, Junyue Xing, Wanjun Zhang, et al.. (2024). An orally administered bacterial membrane protein nanodrug ameliorates doxorubicin cardiotoxicity through alleviating impaired intestinal barrier. Bioactive Materials. 37. 517–532. 11 indexed citations
3.
Shi, Chao, Xin Wang, Sheng Ye, et al.. (2023). Understanding the risk of transmission of respiratory viral infections in childcare centres: protocol for the DISeases TrANsmission in ChildcarE (DISTANCE) multicentre cohort study. BMJ Open Respiratory Research. 10(1). e001617–e001617. 4 indexed citations
4.
Cheng, Xiaolei, Junyue Xing, Dongdong Jian, et al.. (2022). CIRBP-OGFR axis safeguards against cardiomyocyte apoptosis and cardiotoxicity induced by chemotherapy. International Journal of Biological Sciences. 18(7). 2882–2897. 11 indexed citations
5.
Shi, Chao, Mengmeng Li, Rui Sun, et al.. (2022). Real-world clinical treatment outcomes in Chinese non-small cell lung cancer with EGFR exon 20 insertion mutations. Frontiers in Oncology. 12. 949304–949304. 8 indexed citations
7.
Lin, Yao, Guolin Wang, Yuan Shen, et al.. (2021). Persistence of Antibody and Cellular Immune Responses in Coronavirus Disease 2019 Patients Over Nine Months After Infection. The Journal of Infectious Diseases. 224(4). 586–594. 43 indexed citations
8.
Gao, Yumeng, Yu-Jung Chen, Ping Shi, et al.. (2020). The Effect of Ambient Temperature on Infectious Diarrhea and Diarrhea-like Illness in Wuxi, China. Disaster Medicine and Public Health Preparedness. 16(2). 583–589. 11 indexed citations
9.
Gao, Feng, Bo Hu, Ming Y. Lu, et al.. (2020). Outcomes of Hip Arthroscopy for Femoroacetabular Impingement in Chinese Patients Aged 50 Years or Older. Orthopaedic Surgery. 12(3). 843–851. 13 indexed citations
10.
Ji, Hong, Xuefeng Zhang, Jing Ai, et al.. (2019). Surveillance for severe hand, foot, and mouth disease from 2009 to 2015 in Jiangsu province: epidemiology, etiology, and disease burden. BMC Infectious Diseases. 19(1). 79–79. 43 indexed citations
11.
Fu, Jianguang, Changjun Bao, Xiang Huo, et al.. (2019). Increasing Recombinant Strains Emerged in Norovirus Outbreaks in Jiangsu, China: 2015–2018. Scientific Reports. 9(1). 20012–20012. 16 indexed citations
12.
Tian, Yingying, Jiuzhou Zhao, Pengfei Ren, et al.. (2018). Different subtypes of EGFR exon19 mutation can affect prognosis of patients with non-small cell lung adenocarcinoma. PLoS ONE. 13(11). e0201682–e0201682. 19 indexed citations
13.
Sun, Ye, Chao Shi, Xin‐Lou Li, Li‐Qun Fang, & Wu‐Chun Cao. (2018). [Epidemiology of scrub typhus and influencing factors in Yunnan province, 2006-2013].. PubMed. 39(1). 54–57. 6 indexed citations
16.
Shi, Chao, Weihong Feng, Ping Shi, et al.. (2016). An acute gastroenteritis outbreak caused by GII.17 norovirus in Jiangsu Province, China. International Journal of Infectious Diseases. 49. 30–32. 13 indexed citations
17.
Kortüm, K. Martin, Christian Langer, Jorge Monge, et al.. (2015). Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M3P). Annals of Hematology. 94(7). 1205–1211. 36 indexed citations
18.
Wang, Miaomiao, Chao Shi, Yong Xiao, et al.. (2011). [A survey of levels of antibodies against influenza viruses in the population of Wuxi City].. PubMed. 25(5). 351–4. 1 indexed citations
19.
Shi, Chao. (2010). Global Dynamics of an HBV Model with Two Immune Response Sources. Journal of Southwest University. 2 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026